Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
65.33
+4.04 (6.59%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 370 employees as of December 31, 2025. The number of employees increased by 47 or 14.55% compared to the previous year.
Employees
370
Change (1Y)
47
Growth (1Y)
14.55%
Revenue / Employee
$1,638,732
Profits / Employee
-$125,611
Market Cap
2.81B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 370 | 47 | 14.55% |
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Iovance Biotherapeutics | 975 |
| Beam Therapeutics | 522 |
| Nurix Therapeutics | 317 |
| Viridian Therapeutics | 252 |
| uniQure | 221 |
| Immunome | 206 |
| Disc Medicine | 165 |
TARS News
- 20 hours ago - Tarsus to acquire Alkeus Pharmaceuticals for $450M upfront, up to $800M total - TheFly
- 21 hours ago - Tarsus Pharmaceuticals reports Q2 EPS (43c), consensus (20c) - TheFly
- 21 hours ago - Tarsus Pharmaceuticals announces $125M private placement - TheFly
- 21 hours ago - Tarsus Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 21 hours ago - Tarsus Pharmaceuticals Earnings release: Q2 2026 - Filings
- 21 hours ago - Tarsus Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 21 hours ago - Tarsus Pharmaceuticals Slides: Q2 2026 - Filings
- 21 hours ago - Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters